Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in Heavy Drinkers
NCT02989662Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Sep 2017
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mifepristone in alcohol use disorder (AUD) (4 arms), sponsored by Johns Hopkins University. Primary endpoint: Change in Blood Oxygen Level Dependent (BOLD) fMRI Signal for Alcohol Versus Non-alcohol Stimuli at Day 4. Started Sep 2017; status: completed.
02
Drugs
mifepristone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02989662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02989662.